<sup>99m</sup>Tc-3PRGD<sub>2</sub> SPECT Predicts the Outcome of Endostar and Cisplatin Therapy in Xenograft Animals.

Dose Response · 2019 · PMC6804356 · PMID 31673250

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

slightly significantP < .05actually significant

As shown in Figure 2A , there is slightly significant difference of tumor volumes between NaCl group and cisplatin-treated group ( P < .05), but there is highly significant difference between NaCl-treated group and endostar group ( P < .05).

also in 1,756 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.